Page last updated: 2024-09-03

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and dihydroxyphenylalanine

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with dihydroxyphenylalanine in 1 studies

Compound Research Comparison

Studies
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Trials
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Recent Studies (post-2010)
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Studies
(dihydroxyphenylalanine)
Trials
(dihydroxyphenylalanine)
Recent Studies (post-2010) (dihydroxyphenylalanine)
2145588,823322833

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korenstein, R; Madi, L; Nyska, A; Rosenberg-Haggen, B1

Other Studies

1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and dihydroxyphenylalanine

ArticleYear
Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants.
    Experimental dermatology, 2013, Volume: 22, Issue:1

    Topics: Adenosine; Androstadienes; Cell Line, Tumor; Cyclic AMP; Dihydroxyphenylalanine; Humans; In Vitro Techniques; Keratinocytes; MAP Kinase Signaling System; Melanoma, Experimental; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Phosphatidylinositol 3-Kinases; Phosphorylation; Pigmentation; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Receptor, Adenosine A3; Skin; Skin Neoplasms; Wortmannin

2013